Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01160783 · ClinicalTrials.gov registry record
Genetic Contributions to Autism Spectrum Disorders
A clinical trial of Autism Spectrum Disorder and Autism, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT01160783 is a study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 240 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01160783, a study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study will lead to new ways of diagnosing and treating ASDs.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2007-04 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01160783
The ClinicalTrials.gov registry entry for NCT01160783 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (79% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT01160783 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01160783 about?
NCT01160783 is a clinical study titled "Genetic Contributions to Autism Spectrum Disorders". This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study wi...
What is the current status of trial NCT01160783?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2007-04. Estimated completion is 2028-02.
What conditions does trial NCT01160783 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Pervasive Developmental Disorder, Asperger's Syndrome.
Who is sponsoring clinical trial NCT01160783?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01160783 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.